The combination treatment of peptide R and anti-PD-1 reduced the infiltration of forkhead box P3 (FoxP3) positive cells (a major marker of Treg cells), tumor growth, anti-PD-1 sensitivity and tumor drug resistance 149. The gene discussed is FOXP3; the disease is neoplasm.